Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Ltd ADR (NQ: IMRN )

1.960 +0.060 (+3.16%)
Streaming Delayed Price Updated: 11:39 AM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immuron Ltd ADR

< Previous 1 2 3 4 5 6 Next >
Immuron Initiates Recruitment of Travelan® Clinical Study
From Immuron Limited
Via GlobeNewswire
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons, which... 
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
Nasdaq Edges Higher; Six Flags Reports Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite turning higher later during the session on Monday. The Dow traded down 0.20% to 33,606.80 while the NASDAQ rose... 
Via Benzinga
FDA Lifts Clinical Hold From Immuron's New Campylobacter ETEC Therapeutic Study
Immuron Limited (NASDAQ: IMRN) has announced that the U.S. 
Via Benzinga
Why Immuron Stock Is Soaring Today
Immuron Ltd (NASDAQ: IMRN) shares are trading higher Monday after the company announced the FDA removed the clinical hold on its new C 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China. 
Via Benzinga
Crude Oil Rises Over 2%; US Wholesale Inventories Unchanged For March
U.S. stocks traded slightly lower midway through trading, with the Nasdaq Composite dropping around 20 points on Monday. The Dow traded down 0.14% to 33,626.85 while the NASDAQ fell 0.18% to 12,212.88.... 
Via Benzinga
Why Is Immuron (IMRN) Stock Up 67% Today?
Immuron (IMRN) stock is gaining on Monday thanks to an update from the Food and Drug Administration (FDA) on a clinical hold. 
Via InvestorPlace
Palantir (PLTR) Stock Pops Ahead of Earnings
Palantir (PLTR) stock is a hot topic on Monday as investors prepare for the company to report earnings after today's closing bell. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is Tupperware Brands (TUP) Stock Down 8% Today?
Tupperware Brands (TUP) stock is taking a beating on Monday after the company said it's exploring strategic alternatives. 
Via InvestorPlace
Why Is Aptorum (APM) Stock Down 16% Today?
Aptorum (APM) stock is falling on Monday after the biopharmaceutical company received a delisting notice from the Nasdaq. 
Via InvestorPlace
Why Bellicum Pharmaceuticals Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
Gainers Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) gained 105.2% to $0.8001 in pre-market trading. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are a hot topic on Monday as we dive into the biggest winners and losers traders need to know about this morning! 
Via InvestorPlace
Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at Coffee Microcaps
From Immuron Limited
Via GlobeNewswire
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its... 
Via Benzinga
Immuron Q3 FY23 Business Update Presentation
From Immuron Limited
Via GlobeNewswire
Q3 FY23 Business Update Webinar Notification
From Immuron Limited
Via GlobeNewswire
Immuron Q3 Sales reach 150% of 1H Sales
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to host an investor webinar
From Immuron Limited
Via GlobeNewswire
Immuron US DoD Naval Medical Research Center responds to FDA Clinical Hold for New Campylobacter ETEC Therapeutic
From Immuron Limited
Via GlobeNewswire
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™ Achieves 150 Recruitment Milestone
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Immuron Receives European Patent on Drug Composition to Treat Clostridioides difficile Associated Disease
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Dow Rises 150 Points; Mission Produce Shares Slide
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday. 
Via Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.